[Treatment of adult acute lymphoblastie leukemia with eosinophilia and abnormality of PDGFRA by autologous hematopoietic stem cell transplantation and imatinib: one case report and literatures review].
作者信息
Shi Yuanyuan, Yang Donglin, Liu Qingzhen, He Yi, Zhang Rongli, Han Mingzhe, Feng Sizhou
机构信息
Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, China.
出版信息
Zhonghua Xue Ye Xue Za Zhi. 2015 Oct;36(10):866-7. doi: 10.3760/cma.j.issn.0253-2727.2015.10.013.
Abstract
摘要
相似文献
1
[Treatment of adult acute lymphoblastie leukemia with eosinophilia and abnormality of PDGFRA by autologous hematopoietic stem cell transplantation and imatinib: one case report and literatures review].
Zhonghua Xue Ye Xue Za Zhi. 2015 Oct;36(10):866-7. doi: 10.3760/cma.j.issn.0253-2727.2015.10.013.
2
Eosinophilia in Hematologic Disorders.
Immunol Allergy Clin North Am. 2015 Aug;35(3):439-52. doi: 10.1016/j.iac.2015.04.004.
3
[The impact of imatinib on hematopoietic stem cell transplantation for Ph chromosome positive adult acute lymphoblastic leukemia].
Zhonghua Xue Ye Xue Za Zhi. 2015 Sep;36(9):805-8. doi: 10.3760/cma.j.issn.0253-2727.2015.09.021.
4
A novel FOXP1-PDGFRA fusion gene in myeloproliferative neoplasm with eosinophilia.
Cancer Genet. 2015 Oct;208(10):508-12. doi: 10.1016/j.cancergen.2015.07.001. Epub 2015 Jul 14.
5
FIP1L1-PDGFRA fusion gene in T-lymphoblastic lymphoma: A case report.
Cancer Rep (Hoboken). 2023 Jan;6(1):e1769. doi: 10.1002/cnr2.1769. Epub 2022 Dec 14.
6
Dasatinib-induced complete molecular response after allogeneic hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia resistant to prior imatinib-containing regimen: a case report and discussion.
Med Oncol. 2010 Dec;27(4):1123-6. doi: 10.1007/s12032-009-9347-0. Epub 2009 Nov 3.
7
Clinical features predict responsiveness to imatinib in platelet-derived growth factor receptor-alpha-negative hypereosinophilic syndrome.
Allergy. 2016 Jun;71(6):803-10. doi: 10.1111/all.12843. Epub 2016 Mar 2.
8
Exquisite response to imatinib mesylate in FIP1L1-PDGFRA-mutated hypereosinophilic syndrome: a 12-year experience of the Polish Hypereosinophilic Syndrome Study Group.
Pol Arch Intern Med. 2020 Mar 27;130(3):255-257. doi: 10.20452/pamw.15224. Epub 2020 Mar 3.
9
Loeffler endocarditis in chronic eosinophilic leukemia with FIP1L1/PDGFRA rearrangement: full recovery with low dose imatinib.
Korean J Intern Med. 2018 May;33(3):642-644. doi: 10.3904/kjim.2016.100. Epub 2017 Jun 28.
10
Imatinib discontinuation for hypereosinophilic syndrome harboring the FIP1L1-PDGFRA transcript.
Leuk Lymphoma. 2016;57(3):708-10. doi: 10.3109/10428194.2015.1065983. Epub 2015 Oct 2.
本文引用的文献
1
World Health Organization-defined eosinophilic disorders: 2014 update on diagnosis, risk stratification, and management.
Am J Hematol. 2014 Mar;89(3):325-37. doi: 10.1002/ajh.23664.
2
[Autologous stem cell transplantation for adult patients with acute lymphoblastic leukemia and related prognostic factors].
Zhonghua Xue Ye Xue Za Zhi. 2013 Mar;34(3):208-12. doi: 10.3760/cma.j.issn.0253-2727.2013.03.006.
3
[FIP1L1-PDGFRA positive chronic eosinophilic leukemia with imatinib-resistant T674I mutant of PDGFRA gene: a case report and literature review].
Zhonghua Xue Ye Xue Za Zhi. 2013 Feb;34(2):159-61.
4
[Characteristics of cytogenetics and molecular biology in patients with eosinophilia].
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2012 Oct;20(5):1216-20.
5
FIP1L1/PDGFR alpha-associated systemic mastocytosis.
Int Arch Allergy Immunol. 2010;152 Suppl 1(Suppl 1):101-5. doi: 10.1159/000312134. Epub 2010 Jun 4.
6
[The efficacy of imatinib mesylate for patients with myeloproliferative neoplasm (MPN) with eosinophilia].
Zhonghua Xue Ye Xue Za Zhi. 2009 Jun;30(6):381-4.
7
FIP1L1-PDGFRalpha D842V, a novel panresistant mutant, emerging after treatment of FIP1L1-PDGFRalpha T674I eosinophilic leukemia with single agent sorafenib.
Leukemia. 2009 May;23(5):845-51. doi: 10.1038/leu.2009.2. Epub 2009 Feb 12.
8
Eosinophilia with FIP1L1-PDGFRA fusion in a patient with chronic myelomonocytic leukemia.
J Clin Oncol. 2008 Apr 20;26(12):2040-1. doi: 10.1200/JCO.2007.15.3841.
9
Relapse following discontinuation of imatinib mesylate therapy for FIP1L1/PDGFRA-positive chronic eosinophilic leukemia: implications for optimal dosing.
Blood. 2007 Nov 15;110(10):3552-6. doi: 10.1182/blood-2007-07-100164. Epub 2007 Aug 20.
10
Two novel imatinib-responsive PDGFRA fusion genes in chronic eosinophilic leukaemia.
Br J Haematol. 2007 Jul;138(1):77-81. doi: 10.1111/j.1365-2141.2007.06628.x.
Zotero 插件